• share
• favorite_border

The American College of Rheumatology (ACR) today expressed opposition to the Trump Administration’s proposed budget cuts to federal programs and institutions that provide critical resources in the fight against rheumatic diseases, including the National Institutes of Health (NIH), the U.S. Food and Drug Administration (FDA), and the Children’s Health Insurance Program (CHIP). The rheumatology provider community praised budget proposals to repeal the Independent Payment Advisory Board (IPAB) and to increase funding for Graduate Medical Education (GME) programs.

• share
• favorite_border

Today, the American College of Rheumatology submitted comments to the U.S. Food and Drug Administration concerning the draft guidance, ‘Considerations in Demonstrating Interchangeability with a Reference Product’ (FDA 2017-01042).’

• share
• favorite_border

The American College of Rheumatology today praised Congressional leaders for reaching a spending deal that provides a significant boost in federal funding for medical research.

• share
• favorite_border

The decision by U.S. Citizenship and Immigration Services (USCIS) to suspend premium processing of H-1B visas for doctors, specialists, and other medical professionals poses an immediate and dangerous threat to chronically ill patients living in rural and underserved communities throughout the United States, warned the American College of Rheumatology (ACR) today in a letter to the Trump Administration.

• share
• favorite_border

The American College of Rheumatology today announced its 2017 health policy priorities, providing detailed policy recommendations to improve access to rheumatology care and address the national rheumatology workforce shortage. The policy prescriptions come in the wake of a new Centers for Disease Control and Prevention report showing arthritis prevalence is at an all-time high.

• share
• favorite_border

American College of Rheumatology President Sharad Lakhanpal, MBBS, MD, released a statement this morning expressing concern about the American Health Care Act's (AHCA) age-based tax credits and its failure to repeal the Independent Payment Advisory Board.

• share
• favorite_border

The ACR’s Simple Tasks Campaign Recognized Alongside Top National Organizations for Best PSA

• share
• favorite_border

The American College of Rheumatology (ACR) announced the 2016 recipients of its Master of the ACR designation, Awards of Distinction, and Distinguished Fellow Award honors during the opening lecture of the 2016 ACR/ARHP Annual Meeting in Washington D.C. These recognitions are given annually to members who exhibit outstanding contributions to the field of rheumatology.

• share
• favorite_border

Outcomes such as pain, function, range of motion, and strength after total hip arthroplasty, or joint replacement surgery, are different for men & women, which could lead to the development of sex-specific rehabilitation programs, according to new research findings presented this week at the 2016 ACR/ARHP Annual Meeting in Washington.

• share
• favorite_border

Lupus patients who are African-American or Asian, or those who have attained only a high school education or less, had longer delays in seeing a rheumatologist or nephrologist for a confirmed diagnosis than other groups, according to new research findings presented this week at the 2016 ACR/ARHP Annual Meeting in Washington.

• share
• favorite_border

A combination of nonsteroidal anti-inflammatory drugs and TNF-inhibitors may help slow down spine damage in ankylosing spondylitis, according to new research findings presented this week at the 2016 ACR/ARHP Annual Meeting in Washington.

• share
• favorite_border

The gut microbiomes of patients with antiphospholipid syndrome show higher levels of phospholipid-producing bacteria, and this findings point to microbes being a trigger for this life-threatening disease, according to new research findings presented this week at the 2016 ACR/ARHP Annual Meeting in Washington.

• share
• favorite_border

Chronic kidney disease patients who take urate-lowering therapy and achieve target urate levels show improvement in kidney function, according to new research findings presented this week at the 2016 ACR/ARHP Annual Meeting in Washington.

• share
• favorite_border

Distinct gene expression signatures in rheumatoid arthritis patients could help rheumatologists predict how these individuals will respond to tumor necrosis factor inhibitors, and may one day enable a more personalized approach to RA therapy.

• share
• favorite_border

Patients with RA whose rheumatologists and primary-care physicians coordinate their care have a higher likelihood of being screened for hyperlipidemia, a key risk factor for coronary heart disease, according to new research findings presented this week at the 2016 ACR/ARHP Annual Meeting in Washington.

• share
• favorite_border

Over a 15-year period, people with RA may have double the risk of CV events as those in the general population, rates that are similar to people with type-2 diabetes, according to new research findings presented this week at the 2016 ACR/ARHP Annual Meeting in Washington.

• share
• favorite_border

Patients with ankylosing spondylitis or psoriatic arthritis who take statins may have as much as a 33 percent lower mortality risk, according to new research findings presented this week at the 2016 ACR/ARHP Annual Meeting in Washington.

• share
• favorite_border

Three gene expression signatures can help rheumatologists predict which patients are more likely to respond to tumor necrosis factor inhibitors (TNFi) or B-cell depletion therapies in patients with moderate to severe rheumatoid arthritis.

• share
• favorite_border

While patients with inflammatory rheumatic diseases such as RA or spondyloarthritis are at increased risk for CVD, too few are prescribed preventive medications or meeting target goals to prevent heart-related events, according to new research findings presented this week at the 2016 ACR/ARHP Annual Meeting in Washington.

• share
• favorite_border

Rheumatology practices in the United States aren’t always meeting key quality measures for patient care that may affect them as new physician reimbursement laws go into effect in the next year, according to new research findings presented this week at the 2016 ACR/ARHP Annual Meeting in Washington.